Primary |
Product Used For Unknown Indication |
39.5% |
Bipolar Disorder |
15.8% |
Insomnia |
7.9% |
Insomnia Related To Another Mental Condition |
7.9% |
Prostate Cancer |
7.9% |
Drug Dependence |
5.3% |
Sleep Disorder |
5.3% |
Hallucination |
2.6% |
Mental Disorder |
2.6% |
Prophylaxis |
2.6% |
Schizoaffective Disorder |
2.6% |
|
Inappropriate Schedule Of Drug Administration |
20.0% |
Disorientation |
13.3% |
Memory Impairment |
13.3% |
Erythema Multiforme |
6.7% |
Fluid Intake Reduced |
6.7% |
Neuroleptic Malignant Syndrome |
6.7% |
Unevaluable Event |
6.7% |
Unresponsive To Stimuli |
6.7% |
Vomiting |
6.7% |
Weight Increased |
6.7% |
Withdrawal Syndrome |
6.7% |
|
Secondary |
Product Used For Unknown Indication |
36.1% |
Drug Use For Unknown Indication |
21.6% |
Drug Abuse |
6.2% |
Insomnia |
5.9% |
Depression |
5.4% |
Intentional Overdose |
5.0% |
Hypertension |
3.0% |
Anxiety |
2.6% |
Schizophrenia |
2.4% |
Sleep Disorder |
2.2% |
Psychotic Disorder |
1.4% |
Suicide Attempt |
1.2% |
Bipolar Disorder |
1.0% |
Generalised Anxiety Disorder |
1.0% |
Urinary Tract Infection |
1.0% |
Ill-defined Disorder |
0.9% |
Hiv Infection |
0.9% |
Depressed Mood |
0.8% |
Fatigue |
0.7% |
Schizophrenia, Paranoid Type |
0.6% |
|
Suicide Attempt |
16.6% |
Vomiting |
9.6% |
Overdose |
8.9% |
Rhabdomyolysis |
7.2% |
Intentional Overdose |
5.8% |
Somnolence |
4.8% |
Serotonin Syndrome |
4.3% |
Toxicity To Various Agents |
4.3% |
Tremor |
4.1% |
Hypertension |
3.9% |
White Blood Cell Count Increased |
3.9% |
Multiple Drug Overdose |
3.6% |
Weight Increased |
3.6% |
Priapism |
3.4% |
Confusional State |
3.1% |
Completed Suicide |
2.9% |
Drug Toxicity |
2.7% |
Multiple Drug Overdose Intentional |
2.4% |
Respiratory Depression |
2.4% |
Suicidal Ideation |
2.4% |
|
Concomitant |
Product Used For Unknown Indication |
31.0% |
Drug Use For Unknown Indication |
18.4% |
Insomnia |
6.7% |
Depression |
6.3% |
Rheumatoid Arthritis |
4.8% |
Hypertension |
4.3% |
Pain |
4.2% |
Schizophrenia |
3.7% |
Prophylaxis |
3.0% |
Hiv Infection |
2.8% |
Anxiety |
2.4% |
Constipation |
1.9% |
Sleep Disorder |
1.9% |
Diabetes Mellitus |
1.4% |
Non-small Cell Lung Cancer |
1.4% |
Crohn's Disease |
1.2% |
Psychotic Disorder |
1.2% |
Hepatitis C |
1.1% |
Nausea |
1.1% |
Asthma |
1.1% |
|
Vomiting |
13.8% |
Death |
6.9% |
Renal Failure Acute |
6.4% |
Suicidal Ideation |
5.7% |
Tremor |
5.5% |
Thrombocytopenia |
5.3% |
Weight Increased |
5.2% |
Urinary Tract Infection |
4.9% |
White Blood Cell Count Decreased |
4.7% |
Suicide Attempt |
4.3% |
Weight Decreased |
4.3% |
Nausea |
4.2% |
Pyrexia |
3.9% |
Pneumonia |
3.9% |
Pulmonary Embolism |
3.7% |
Syncope |
3.6% |
Renal Failure |
3.5% |
Withdrawal Syndrome |
3.5% |
Sudden Death |
3.4% |
Drug Interaction |
3.3% |
|
Interacting |
Drug Use For Unknown Indication |
29.5% |
Product Used For Unknown Indication |
23.2% |
Bipolar Disorder |
5.8% |
Hiv Infection |
5.3% |
Staphylococcal Infection |
5.3% |
Pain |
4.8% |
Emotional Distress |
3.9% |
Insomnia |
2.9% |
Schizoaffective Disorder |
2.9% |
Anxiety |
1.9% |
Constipation |
1.9% |
Hypertension |
1.9% |
Mental Disorder |
1.9% |
Sleep Disorder |
1.9% |
Cardiovascular Disorder |
1.4% |
Schizophrenia |
1.4% |
Abdominal Pain Upper |
1.0% |
Atrial Fibrillation |
1.0% |
Attention Deficit/hyperactivity Disorder |
1.0% |
Back Pain |
1.0% |
|
Hypertension |
20.4% |
Somnolence |
14.8% |
Drug Interaction |
11.1% |
Drug Toxicity |
7.4% |
Toxicity To Various Agents |
5.6% |
Unresponsive To Stimuli |
5.6% |
Homicide |
3.7% |
Multiple Drug Overdose |
3.7% |
Renal Atrophy |
3.7% |
Restlessness |
3.7% |
Suicide Attempt |
3.7% |
Fall |
1.9% |
Femur Fracture |
1.9% |
Hallucination, Auditory |
1.9% |
Heart Rate Increased |
1.9% |
Nausea |
1.9% |
Respiratory Distress |
1.9% |
Sleep Disorder |
1.9% |
Vital Functions Abnormal |
1.9% |
Vomiting |
1.9% |
|